Clinical evaluation of Epigard, a new synthetic substitute for homograft and heterograft skin.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002056:Burns / Q000473:pathology / Q000628:therapy*; D002102:Cadaver; D003646:Debridement; D006097:Granulation Tissue; D006168:Guinea Pigs; D006801:Humans; D009824:Ointments; D011140:Polyurethanes; D016038:Skin Transplantation; D014014:Tissue Adhesives; D014183:Transplantation, Heterologous; D014184:Transplantation, Homologous; D014945:Wound Healing
D000900:Anti-Bacterial Agents; D009824:Ointments; D011140:Polyurethanes; D014014:Tissue Adhesives